16.4: Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.

Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in their dose-response relationship, making them potentially fatal if not carefully administered. In contrast, newer drugs, such as benzodiazepines, have a non-linear dose-response relationship, making them safer sedative-hypnotic options, as only extremely high doses lead to severe CNS depression.

The primary targets of sedatives are the GABA_A ligand-gated ion channels, while the primary targets of hypnotics are melatonin G protein-coupled receptors. GABA_A ion channels are opened when the neurotransmitter GABA binds to them, allowing an influx of chloride ions. This process decreases the resting potential of neurons, inhibiting neuronal firing and leading to the calming effect observed with sedatives.

Barbiturates, benzodiazepines, and non-benzodiazepine drugs such as zolpidem (Ambien) act on different allosteric sites on the GABA_A channel. By promoting GABA binding to these sites, these drugs enhance the inhibitory effect on neurons, suppressing brain activity.

Additionally, melatonin, a hormone that regulates sleep-wake cycles, activates MT₁ and MT₂ GPCRs in the anterior hypothalamus. Activation of these receptors decreases neuronal firing, promoting sleep. Melatonin analogs, such as ramelteon (Rozerem), mimic the effects of melatonin and are helpful for insomnia without posing a risk of dependency.

Understanding the intricate mechanisms of these drugs is crucial for healthcare professionals to prescribe them effectively, balancing the need for anxiety relief or inducing sleep while minimizing the risks associated with their use. Careful consideration of dosage and patient response is vital in ensuring sedative-hypnotic medications' safe and beneficial effects.

Sedatives belong to a class of drugs that calms the individual, while hypnotics induce and maintain sleep. Both categories work by slowing down the brain activity.

Sedative-hypnotic drugs suppress the CNS activity in a dose-dependent manner. Older medications like barbiturates follow a linear curve, making them potentially fatal. Newer drugs like benzodiazepines deviate from the linear curve, making them useful for short-term relief.

Sedative-hypnotic drugs primarily target GABA_A ligand-gated ion channels and melatonin GPCRs.

Neurotransmitter GABA binds and opens the GABA_A ion channel, allowing chloride ion influx, decreasing the resting potential and, in turn, inhibiting neuronal firing.

Barbiturates, benzodiazepines, and newer agents like zolpidem bind at different allosteric sites on the GABA_A channel, promoting GABA binding and neuronal suppression.

In addition, melatonin activates MT₁ and MT₂ GPCRs in the anterior hypothalamus, decreasing neuronal firing and promoting sleep. Melatonin analogs, such as ramelteon, are helpful for insomnia without any dependency risk.